PHARMACEUTICAL CARE MANAGEMENT ASS… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

AGNITA KOTE

Phone

2027565700

Tax Period

2023-01-01 to 2023-12-31

PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION, founded in 2003, is a mid-sized nonprofit that reported $61.7M in total revenue in fiscal year 2023. Revenue surged 30% from the prior year, signaling strong growth momentum.

Mission

PCMA'S VISION AND MISSION ARE TO HELP PEOPLE OPTIMIZE PRESCRIPTION DRUG THERAPY TO LIVE HEALTHIER LIVES. WE STRIVE TO CREATE A FAVORABLE PUBLIC POLICY AND BUSINESS ENVIRONMENT FOR THE PHARMACEUTICAL CARE BENEFITS MANAGERS INDUSTRY (PBM) TO ACHIEVE POSITIVE HEALTHCARE OUTCOMES FOR PATIENTS BY MANAGING ACCESS TO APPROPRIATE, AFFORDABLE, AND SAFE PRESCRIPTION DRUGS.

Program Service Accomplishments

Program 1

PCMA SHAPES PRO-PBM FEDERAL AND STATE LEGISLATIVE AND REGULATORY ENVIRONMENTS BY ADVANCING PCMA MEMBER COMPANY APPROVED POLICY PRIORITIES.

Program 2

PCMA'S OBJECTIVE IS TO BUILD A FOUNDATIONAL UNDERSTANDING OF THE VALUE OF THE PBM INDUSTRY AMONG FEDERAL AND STATE POLICYMAKERS, THOUGHT LEADERS AND THE MEDIA.

Program 3

PCMA'S GOAL IS TO DEEPEN THE PBM'S RELATIONSHIP WITH PATIENT GROUPS, HEALTHCARE PROVIDERS, PAYORS, DRUG MAKERS AND OTHER STAKEHOLDERS IN THE PHARMACEUTICAL SUPPLY CHAIN TO FIND AREAS OF ALIGNMENT...

PCMA'S GOAL IS TO DEEPEN THE PBM'S RELATIONSHIP WITH PATIENT GROUPS, HEALTHCARE PROVIDERS, PAYORS, DRUG MAKERS AND OTHER STAKEHOLDERS IN THE PHARMACEUTICAL SUPPLY CHAIN TO FIND AREAS OF ALIGNMENT THAT WILL BUILD STRATEGIES TO MITIGATE CONFLICTS AND BUILD POSITIVE RELATIONSHIPS BETWEEN INDUSTRIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $60,878,729

Investment Income $809,045

Other Revenue $0

TOTAL REVENUE $61,687,774

Expense Breakdown

Grants Paid $477,850

Salaries & Benefits $17,556,213

Fundraising Expenses $0

Other Expenses $44,305,443

TOTAL EXPENSES $62,339,506

Year-over-Year Comparison

	2023	2022	Change
Revenue	$61,687,774	$47,371,719	+0.3%
Expenses	$62,339,506	$47,414,705	+0.3%
Net Income	$-651,732	$-42,986	+14.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✓ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$4,719,589

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PATRICK CONWAY	DIRECTOR	1.00	Director	$0	$0	$0
CHRIS DUPAUL	DIRECTOR	1.00	Director	$0	$0	$0
WILLIAM FLEMING	DIRECTOR	1.00	Director	$0	$0	$0
JAMES GARTNER	DIRECTOR	1.00	Director	$0	$0	$0
DAVID JOYNER	DIRECTOR	1.00	Director	$0	$0	$0
MOSTAFA KAMAL	DIRECTOR	1.00	Director	$0	$0	$0
ADAM KAUTZNER	DIRECTOR	1.00	Director	$0	$0	$0
PAUL MARCHETTI	DIRECTOR	1.00	Director	$0	$0	$0
RAY MARSELLA	DIRECTOR	1.00	Director	$0	$0	$0
JUAN CARLOS SCOTT	PRESIDENT & CEO	40.00	Officer	$1,428,471	$104,925	$1,533,396
KRISTIN BASS	CHIEF POLICY AND EXTERNAL AFFAIRS OFFICER	40.00	Officer	$1,004,698	$92,528	$1,097,226
BRIAN MCCARTHY	CHIEF STRATEGY AND BUSINESS OPERATIONS OFFICER	40.00	Officer	$979,350	$109,201	$1,088,551
JOHN S LINEHAN	GENERAL COUNSEL	40.00	Officer	$571,750	$81,238	$652,988
AGNITA KOTE	CHIEF FINANCIAL OFFICER	40.00	Officer	$292,999	$54,429	$347,428
LAUREN ROWLEY	SVP STATE AFFAIRS	40.00	Highest	$683,946	$66,389	$750,335
KATIE PAYNE	SVP STRATEGIC COMMUNICATIONS	40.00	Highest	$604,160	$85,822	$689,982
JONATHAN HEAFITZ	VP FEDERAL AFFAIRS	40.00	Highest	$541,779	$81,868	$623,647
LUCIA LEBENS	SVP FEDERAL AFFAIRS	40.00	Highest	$488,670	$76,965	$565,635
TIM DUBE	VP REGULATORY AFFAIRS	40.00	Highest	$471,020	$77,771	$548,791

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$61,687,774	$62,339,506	$26,947,681	$-651,732
2022	$47,371,719	$47,414,705	$25,360,425	$-42,986
2021	$37,563,344	$32,994,802	$26,215,317	$4,568,542
2020	$31,028,786	$30,664,588	$21,617,621	$364,198
2019	$28,534,976	$27,523,420	$15,895,913	$1,011,556
2018	$28,068,221	$27,283,308	$18,991,760	$784,913

PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION